ARCHIVES

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 9 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

November 15, 1991

NCI Preparing RFA for Genetics Network; Patients Want Gene-Environment Studies

August 9, 1996

Three cancer societies to be led by Vanderbilt faculty in 2004

July 18, 2003

Oxford Univ. Receives Funds To Create Drug Design Center.

October 6, 2000

Former Senator Cotton Named To NCA

April 11, 1975

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989